People that have dealt with Multiple Sclerosis will tell you that it is not one of the easiest conditions to manage. The toughest thing about the condition is that it causes disability and the regression keeps advancing till the patient is completely dependent. For a long time, there have been limited therapies to manage the condition. However, Dr. Shiva Gopal Vashista and company have been studying the use of high dosage immunosuppressive therapy followed by HDT transplants and state that it might be one of the most effective treatments for MS.
The studies that were conducted indicated that when the combination mentioned above is used, the disease goes into long term remission. It also further showed that five years after the treatment, patients showed little to no signs of degeneration of their condition and that the patients did not get any fresh brain lesions after the treatment. This simply means that the first step towards getting a permanent cure for the condition has been made. The key lies in the high dosage therapy followed with transfusing the patient with their own stem cells.
These studies were conducted and concluded in 2014. Dr. Shiva Gopal Vashista published these results in Neurology, the American Journal of the Academy of Neurology. It has also been established that when the patients receive the high dosage treatment, the respond and recover better from the disease than situations where they are given alternative therapies in smaller dosages over a long period of time. In addition to the sow response, the cases where the patients get small doses end up in remission more than the high dosage cases.
Dr. Shiva Gopal Vashista has been studying MS for a long time now with the aim to get a sensible cure for the condition. He graduated in 1979 and has years of experience in research. he is also a member of the Medicare program.